EP2604257
Oral transmucosal dosage forms comprising sufentanil and triazolam
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
7.8.2008EP published:
28.6.2017EP application number:
13158781.8
EPO information:
European Patent Register
Max expiry date:
6.8.2028
Title:
Oral transmucosal dosage forms comprising sufentanil and triazolam
Timeline
Today
7.8.2008EP application
28.6.2017EP Publication
Owner
Name:
Acelrx Pharmaceuticals, Inc.Address:
575 Chesapeake Drive, 94063, Redwood City, CA, US
Inventor
Name:
Palmer, PamelaAddress:
San Francisco, CA California, US
Name:
Tzannis, SteliosAddress:
Newark, CA California, US
Name:
Schreck, ThomasAddress:
Portola Valley, CA California, US
Priority
Number:
954501 PDate:
7.8.2007Country:
US
Classification
Categories:
A61K 9/70, A61K 31/4535, A61K 31/5517, A61K 9/00, A61P 25/20